These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 16328345

  • 1. Elevated levels of serum soluble Fas are associated with organ and tissue damage in systemic lupus erythematosus among Chinese.
    Hao JH, Ye DQ, Zhang GQ, Liu HH, Dai H, Huang F, Pan FM, Su H, Dong MX, Chen H, Wang Q, Zhang XJ.
    Arch Dermatol Res; 2006 Jan; 297(7):329-32. PubMed ID: 16328345
    [Abstract] [Full Text] [Related]

  • 2. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
    Bijl M, van Lopik T, Limburg PC, Spronk PE, Jaegers SM, Aarden LA, Smeenk RJ, Kallenberg GG.
    J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Correlation between serum levels of soluble Fas (CD95/Apo-1) with disease activity in systemic lupus erythematosus patients in Khorasan, Iran.
    Sahebari M, Hatef MR, Rezaieyazdi Z, Abbasi M, Abbasi B, Mahmoudi M.
    Arch Iran Med; 2010 Mar; 13(2):135-42. PubMed ID: 20187668
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serum DNase I, soluble Fas/FasL levels and cell surface Fas expression in patients with SLE: a possible explanation for the lack of efficacy of hrDNase I treatment.
    Tinazzi E, Puccetti A, Gerli R, Rigo A, Migliorini P, Simeoni S, Beri R, Dolcino M, Martinelli N, Corrocher R, Lunardi C.
    Int Immunol; 2009 Mar; 21(3):237-43. PubMed ID: 19181929
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A, Ciolkiewicz M, Klimiuk PA, Sierakowski S.
    Scand J Rheumatol; 2009 Jun; 38(1):38-45. PubMed ID: 18991188
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Serum sFas/sFasL ratio in systemic lupus erythematosus (SLE) is a function of age.
    Turi MC, D'Urbano M, Celletti E, Alessandri C, Valesini G, Paganelli R.
    Arch Gerontol Geriatr; 2009 Jun; 49 Suppl 1():221-6. PubMed ID: 19836636
    [Abstract] [Full Text] [Related]

  • 14. Soluble TRAIL concentrations are raised in patients with systemic lupus erythematosus.
    Lub-de Hooge MN, de Vries EG, de Jong S, Bijl M.
    Ann Rheum Dis; 2005 Jun; 64(6):854-8. PubMed ID: 15564310
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serological levels of apoptotic bodies, sFAS and TNF in lupus erythematosus.
    Alecu M, Coman G, Alecu S.
    Rom J Intern Med; 2005 Jun; 38-39():83-8. PubMed ID: 15529575
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Homocysteine levels and disease duration independently correlate with coronary artery calcification in patients with systemic lupus erythematosus.
    Von Feldt JM, Scalzi LV, Cucchiara AJ, Morthala S, Kealey C, Flagg SD, Genin A, Van Dyke AL, Nackos E, Chander A, Gehrie E, Cron RQ, Whitehead AS.
    Arthritis Rheum; 2006 Jul; 54(7):2220-7. PubMed ID: 16802358
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
    Kuryliszyn-Moskal A, Klimiuk PA, Ciolkiewicz M, Sierakowski S.
    J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.